Search research articles
Contact Us
Filters
Showing results (111-120 of 322) with videos related to
Page
of 33
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 15, 2011
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation
Koen van Besien, Wendy Stock, Elizabeth Rich, et al.
Leukemia & Lymphoma
|
February 20, 2016
Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665
Rebecca DeBoer, Gregory Koval, Flora Mulkey, et al.
Leukemia & Lymphoma
|
August 3, 2018
Characterization of cancer comorbidity prior to allogeneic hematopoietic cell transplantation
Christopher R D'Angelo, Brianna Novitsky, Sang Mee Lee, et al.
Breast Cancer Research and Treatment
|
October 24, 2009
Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012)
Marilyn L Slovak, Victoria Bedell, Danika Lew, et al.
British Journal of Haematology
|
May 3, 2020
Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib
Anand A Patel, Kirk Cahill, Angella Charnot-Katsikas, et al.
Oncotarget
|
November 4, 2014
Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia
Houda Alachkar, Martin B G Mutonga, Klaus H Metzeler, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 20, 2015
A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia
Christopher R Flowers, Jennifer R Brown, Hilary Rosenthal, et al.
Annals of Translational Medicine
|
June 24, 2024
FLT3 inhibitor maintenance after allogeneic stem cell transplantation in <i>FLT3</i>-mutated acute myeloid leukemia (AML) patients
Gong He, Erika Belmont, Theodore Karrison, et al.
Journal of Oncology Practice
|
November 14, 2018
Treatment of Acute Promyelocytic Leukemia in Adults
Afaf E G Osman, Jennifer Anderson, Jane E Churpek, et al.
Leukemia & Lymphoma
|
March 11, 2017
Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia
Niloufer Khan, Andrew Hantel, Randall W Knoebel, et al.
Page
of 33
Search research articles
Search
Showing results (111-120 of 322) with videos related to
Sort By:
Page
of 33
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 15, 2011
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation
Koen van Besien, Wendy Stock, Elizabeth Rich, et al.
Leukemia & Lymphoma
|
February 20, 2016
Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665
Rebecca DeBoer, Gregory Koval, Flora Mulkey, et al.
Leukemia & Lymphoma
|
August 3, 2018
Characterization of cancer comorbidity prior to allogeneic hematopoietic cell transplantation
Christopher R D'Angelo, Brianna Novitsky, Sang Mee Lee, et al.
Breast Cancer Research and Treatment
|
October 24, 2009
Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012)
Marilyn L Slovak, Victoria Bedell, Danika Lew, et al.
British Journal of Haematology
|
May 3, 2020
Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib
Anand A Patel, Kirk Cahill, Angella Charnot-Katsikas, et al.
Oncotarget
|
November 4, 2014
Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia
Houda Alachkar, Martin B G Mutonga, Klaus H Metzeler, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 20, 2015
A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia
Christopher R Flowers, Jennifer R Brown, Hilary Rosenthal, et al.
Annals of Translational Medicine
|
June 24, 2024
FLT3 inhibitor maintenance after allogeneic stem cell transplantation in <i>FLT3</i>-mutated acute myeloid leukemia (AML) patients
Gong He, Erika Belmont, Theodore Karrison, et al.
Journal of Oncology Practice
|
November 14, 2018
Treatment of Acute Promyelocytic Leukemia in Adults
Afaf E G Osman, Jennifer Anderson, Jane E Churpek, et al.
Leukemia & Lymphoma
|
March 11, 2017
Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia
Niloufer Khan, Andrew Hantel, Randall W Knoebel, et al.
Page
of 33